EADV HS Capital Markets Call

Bimzelx long term impact on tunnels and potential to prevent disease progression in HS

The briefing has taken place on Thursday October 1st, 2026 on the occasion of the data presentation at EADV

 

The videoconference webcast (including a Q&A session) was hosted by:

Emmanuel Caeymaex : Executive Vice President, Head of Patient Evidence (UCB)

Professor Amit Garg: Professor & Founding Chair, Department of Dermatology, Zucker School of Medicine at Hofstra/Northwell Professor, Center for Health Innovations & Outcomes Research, Feinstein Institutes for Medical Research 

Materials 

Please find the presentation here